Home
About Us
Our Science
Pipeline
Careers
Media
Contact

Select Page

BioCentury Article

Oct 15, 2021

Emerging Company Profile – Origami: Correcting or eliminating misfolded proteins. Learn More

Search

Recent Posts

Attacking Neurodegenerative Diseases with Protein Degraders
Origami Brings Protein Degradation to Neurodegenerative Disorders
Founder Spotlight #36: Beth Hoffman @ Origami Therapeutics
CEO Beth Hoffman guest on the Personalized Medicine Podcast
Origami named part of the W22 Batch at Y Combinator

Recent Comments

No comments to show.

origami_therapeutics_logo_white-01

Origami Therapeutics, Inc.
10210 Campus Point Road, Suite 150
San Diego, CA 92121

info@origamitherapeutics.com